Clinical Trial Update: A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333 [Phase 1]

View source ↗

Summary

Phase 1 study in healthy adults to evaluate safety, tolerability, and pharmacokinetics of multiple doses of ABT-333 for hepatitis C infection; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-333 (ABT-333)

Snippet

Sponsor: Abbott | Conditions: HCV Infection | Phase 1 | Status: COMPLETED